SGLT-2 inhibitor, cardiovascular risk and outcome in patients with comorbidity of hypertension and diabetes [Cardiovascular disease]
Annals of Family Medicine
NOVEMBER 20, 2024
Objective This study aims to investigate the effects of SGLT-2 inhibitors on level of cardiovascular risk (evaluate by China-PAR) and hospitalization events in patient with comorbidity of hypertension and diabetes. Setting or Dataset Five electronic systems of community clinic. Intervention Taking SGLT-2 inhibitors more than 3 months.
Let's personalize your content